OptimizeRx (OPRX) Notes Payables (2010 - 2020)
OptimizeRx (OPRX) reported Notes Payables of $285795.0 for Q4 2020, down 50.73% on a YoY basis from $580014.0 in Q1 2020, and down 50.73% sequentially from $580014.0 in Q4 2019.
OptimizeRx (OPRX) Notes Payables (2010 - 2020) Analysis & Trends
OptimizeRx (OPRX) has 6 years of Notes Payables data on file, last reported at $285795.0 in Q4 2020.
- For the quarter ending Q4 2020, Notes Payables fell 50.73% year-over-year to $285795.0; the trailing twelve-month figure through Dec 2020 stood at $285795.0 (down 50.73% YoY), and the FY2020 full-year result was $285795.0, down 50.73% from the prior year.
- Notes Payables fell to $285795.0 in Q4 2020, from $580014.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $580014.0 in Q4 2019 to a low of $285795.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 32.25 Bn | 24.94 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 14.59 Bn | 13.69 Bn | 482.22 Mn |
| 3 | Healthequity | 8.33 Bn | 8.07 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.98 Bn | 5.67 Bn | 154.23 Mn |
| 5 | 10x Genomics | 5.88 Bn | 5.34 Bn | 106.18 Mn |
| 6 | MiniMed | 4.49 Bn | 4.20 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.48 Bn | 4.41 Bn | 216.84 Mn |
| 8 | Doximity | 3.97 Bn | 3.22 Bn | 125.97 Mn |
| 9 | Privia Health | 3.13 Bn | 2.71 Bn | - |
| 10 | OptimizeRx | 119.89 Mn | 99.72 Mn | 14.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 285,795.00 |
| Dec 31, 2019 | 580,014.00 |
| Dec 31, 2015 | 570,000.00 |
| Sep 30, 2015 | 570,000.00 |
| Jun 30, 2015 | 570,000.00 |
| Mar 31, 2015 | 570,000.00 |
| Dec 31, 2014 | 570,000.00 |
| Sep 30, 2014 | 570,000.00 |
| Dec 31, 2013 | 570,000.00 |
| Dec 31, 2010 | 570,000.00 |